| 摘要 |
The present invention relates to the prognosticating survival of subjects with cancer. More specifically, the invention relates to methods and systems to prognosticate cancer patients by assaying RANKL, NRP-1, p-NF-kB, p-c-Met, VEGF and/or RANK expression levels and comparing those levels to reference values to determine the likelihood of survival. The present invention also provides for methods of selecting appropriate therapies for patients based on their prognosis. |
